Insufficient scRNA-seq data for expression of MMP3 at single-cell level.
Insufficient scRNA-seq data for expression of MMP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 68% | 3495.56 | 313 / 459 | 72% | 29.92 | 803 / 1118 |
stomach | 31% | 621.09 | 112 / 359 | 74% | 70.66 | 212 / 286 |
intestine | 29% | 424.26 | 280 / 966 | 75% | 88.78 | 394 / 527 |
bladder | 43% | 1215.10 | 9 / 21 | 50% | 49.75 | 251 / 504 |
esophagus | 8% | 73.16 | 119 / 1445 | 79% | 90.92 | 145 / 183 |
skin | 57% | 6311.36 | 1029 / 1809 | 19% | 7.34 | 89 / 472 |
tonsil | 0% | 0 | 0 / 0 | 53% | 38.93 | 24 / 45 |
uterus | 4% | 16.68 | 6 / 170 | 49% | 39.51 | 227 / 459 |
muscle | 52% | 2301.30 | 415 / 803 | 0% | 0 | 0 / 0 |
lung | 1% | 5.78 | 6 / 578 | 36% | 20.22 | 419 / 1155 |
adipose | 31% | 5025.84 | 373 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0.84 | 1 / 328 | 27% | 20.60 | 48 / 178 |
prostate | 18% | 170.64 | 43 / 245 | 1% | 0.26 | 6 / 502 |
blood vessel | 17% | 232.30 | 233 / 1335 | 0% | 0 | 0 / 0 |
thymus | 10% | 280.56 | 67 / 653 | 3% | 2.74 | 17 / 605 |
lymph node | 0% | 0 | 0 / 0 | 7% | 4.61 | 2 / 29 |
kidney | 3% | 16.67 | 3 / 89 | 1% | 0.17 | 10 / 901 |
liver | 2% | 132.86 | 5 / 226 | 2% | 0.36 | 7 / 406 |
ovary | 1% | 7.06 | 2 / 180 | 2% | 0.78 | 10 / 430 |
brain | 0% | 2.85 | 11 / 2642 | 2% | 0.38 | 13 / 705 |
adrenal gland | 0% | 1.19 | 1 / 258 | 1% | 0.26 | 2 / 230 |
heart | 0% | 4.15 | 4 / 861 | 0% | 0 | 0 / 0 |
spleen | 0% | 1.10 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0150077 | Biological process | regulation of neuroinflammatory response |
GO_0045087 | Biological process | innate immune response |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_1904645 | Biological process | response to amyloid-beta |
GO_2000378 | Biological process | negative regulation of reactive oxygen species metabolic process |
GO_0071732 | Biological process | cellular response to nitric oxide |
GO_0030574 | Biological process | collagen catabolic process |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0030334 | Biological process | regulation of cell migration |
GO_0006508 | Biological process | proteolysis |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0030163 | Biological process | protein catabolic process |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0071492 | Biological process | cellular response to UV-A |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005739 | Cellular component | mitochondrion |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0008233 | Molecular function | peptidase activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | MMP3 |
Protein name | MMP3 Matrix metallopeptidase 3 Stromelysin-1 (SL-1) (EC 3.4.24.17) (Matrix metalloproteinase-3) (MMP-3) (Transin-1) Matrix metalloproteinase 3 |
Synonyms | STMY1 |
Description | FUNCTION: Metalloproteinase with a rather broad substrate specificity that can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates different molecules including growth factors, plasminogen or other matrix metalloproteinases such as MMP9 . Once released into the extracellular matrix (ECM), the inactive pro-enzyme is activated by the plasmin cascade signaling pathway . Acts also intracellularly . For example, in dopaminergic neurons, gets activated by the serine protease HTRA2 upon stress and plays a pivotal role in DA neuronal degeneration by mediating microglial activation and alpha-synuclein/SNCA cleavage . In addition, plays a role in immune response and possesses antiviral activity against various viruses such as vesicular stomatitis virus, influenza A virus (H1N1) and human herpes virus 1 . Mechanistically, translocates from the cytoplasm into the cell nucleus upon virus infection to influence NF-kappa-B activities . . |
Accessions | ENST00000299855.10 A0A0U3J4I2 ENST00000524478.1 E9PKX2 P08254 H7C139 A5GZ70 ENST00000434103.1 |